keats pharmacy limited Company Information
Group Structure
View All
Industry
Other human health activities
Registered Address
30 rosslyn hill, hampstead, london, NW3 1NH
Website
www.keatspharmacy.comkeats pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of KEATS PHARMACY LIMITED at £193.8k based on a Turnover of £398.5k and 0.49x industry multiple (adjusted for size and gross margin).
keats pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of KEATS PHARMACY LIMITED at £0 based on an EBITDA of £-12.8k and a 3.75x industry multiple (adjusted for size and gross margin).
keats pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of KEATS PHARMACY LIMITED at £224.7k based on Net Assets of £95.7k and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Keats Pharmacy Limited Overview
Keats Pharmacy Limited is a live company located in london, NW3 1NH with a Companies House number of 01673810. It operates in the other human health activities sector, SIC Code 86900. Founded in October 1982, it's largest shareholder is countcredit ltd with a 100% stake. Keats Pharmacy Limited is a mature, micro sized company, Pomanda has estimated its turnover at £398.5k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Keats Pharmacy Limited Health Check
Pomanda's financial health check has awarded Keats Pharmacy Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 8 areas for improvement. Company Health Check FAQs


2 Strong

2 Regular

8 Weak

Size
annual sales of £398.5k, make it smaller than the average company (£798.8k)
- Keats Pharmacy Limited
£798.8k - Industry AVG

Growth
3 year (CAGR) sales growth of -6%, show it is growing at a slower rate (6.5%)
- Keats Pharmacy Limited
6.5% - Industry AVG

Production
with a gross margin of 36.6%, this company has a comparable cost of product (36.6%)
- Keats Pharmacy Limited
36.6% - Industry AVG

Profitability
an operating margin of -4.1% make it less profitable than the average company (5.5%)
- Keats Pharmacy Limited
5.5% - Industry AVG

Employees
with 4 employees, this is below the industry average (19)
4 - Keats Pharmacy Limited
19 - Industry AVG

Pay Structure
on an average salary of £27k, the company has an equivalent pay structure (£27k)
- Keats Pharmacy Limited
£27k - Industry AVG

Efficiency
resulting in sales per employee of £99.6k, this is more efficient (£51.5k)
- Keats Pharmacy Limited
£51.5k - Industry AVG

Debtor Days
it gets paid by customers after 28 days, this is later than average (23 days)
- Keats Pharmacy Limited
23 days - Industry AVG

Creditor Days
its suppliers are paid after 68 days, this is slower than average (17 days)
- Keats Pharmacy Limited
17 days - Industry AVG

Stock Days
it holds stock equivalent to 101 days, this is more than average (16 days)
- Keats Pharmacy Limited
16 days - Industry AVG

Cash Balance
has cash to cover current liabilities for 20 weeks, this is less cash available to meet short term requirements (101 weeks)
20 weeks - Keats Pharmacy Limited
101 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 38.6%, this is a higher level of debt than the average (27.9%)
38.6% - Keats Pharmacy Limited
27.9% - Industry AVG
KEATS PHARMACY LIMITED financials

Keats Pharmacy Limited's latest turnover from December 2023 is estimated at £398.5 thousand and the company has net assets of £95.7 thousand. According to their latest financial statements, Keats Pharmacy Limited has 4 employees and maintains cash reserves of £22.8 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | |||||||||||||||
Gross Profit | |||||||||||||||
Admin Expenses | |||||||||||||||
Operating Profit | |||||||||||||||
Interest Payable | |||||||||||||||
Interest Receivable | |||||||||||||||
Pre-Tax Profit | |||||||||||||||
Tax | |||||||||||||||
Profit After Tax | |||||||||||||||
Dividends Paid | |||||||||||||||
Retained Profit | |||||||||||||||
Employee Costs | |||||||||||||||
Number Of Employees | 4 | 4 | 4 | 4 | 4 | 4 | |||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 10,986 | 14,648 | 19,531 | 15,844 | 21,125 | 28,166 | 10,997 | 14,662 | 19,548 | 26,063 | 34,750 | 44,952 | 59,936 | 78,508 | 101,127 |
Intangible Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
Investments & Other | |||||||||||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 10,987 | 14,649 | 19,532 | 15,845 | 21,126 | 28,167 | 10,997 | 14,662 | 19,549 | 26,064 | 34,751 | 44,953 | 59,937 | 78,509 | 101,128 |
Stock & work in progress | 70,328 | 75,483 | 58,729 | 60,812 | 72,778 | 71,924 | 102,278 | 95,885 | 97,640 | 98,960 | 101,445 | 98,776 | 102,732 | ||
Trade Debtors | 31,047 | 33,591 | 41,615 | 37,793 | 38,836 | 29,354 | 347,179 | 317,137 | 119,300 | 71,491 | 105,865 | 117,101 | 85,613 | 92,872 | 86,349 |
Group Debtors | 221,823 | ||||||||||||||
Misc Debtors | 20,690 | 27,130 | 18,608 | 12,406 | 16,533 | 21,433 | |||||||||
Cash | 22,844 | 51,895 | 59,794 | 92,895 | 49,229 | 17,659 | 56,897 | 59,780 | 48,667 | 12,226 | 8,885 | 60 | 60 | ||
misc current assets | 3,653 | ||||||||||||||
total current assets | 144,909 | 188,099 | 178,746 | 203,906 | 181,029 | 362,193 | 347,179 | 317,137 | 278,475 | 227,156 | 252,172 | 228,287 | 195,943 | 191,708 | 189,141 |
total assets | 155,896 | 202,748 | 198,278 | 219,751 | 202,155 | 390,360 | 358,176 | 331,799 | 298,024 | 253,220 | 286,923 | 273,240 | 255,880 | 270,217 | 290,269 |
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 47,252 | 63,860 | 66,671 | 56,579 | 83,188 | 61,417 | 26,323 | 27,152 | 24,251 | 21,431 | 49,987 | 51,716 | 53,857 | 80,348 | 101,750 |
Group/Directors Accounts | |||||||||||||||
other short term finances | |||||||||||||||
hp & lease commitments | |||||||||||||||
other current liabilities | 10,451 | 26,171 | 24,424 | 30,556 | 5,500 | 5,675 | |||||||||
total current liabilities | 57,703 | 90,031 | 91,095 | 87,135 | 88,688 | 67,092 | 26,323 | 27,152 | 24,251 | 21,431 | 49,987 | 51,716 | 53,857 | 80,348 | 101,750 |
loans | |||||||||||||||
hp & lease commitments | |||||||||||||||
Accruals and Deferred Income | |||||||||||||||
other liabilities | |||||||||||||||
provisions | 2,525 | 2,577 | 3,460 | 2,704 | |||||||||||
total long term liabilities | 2,525 | 2,577 | 3,460 | 2,704 | |||||||||||
total liabilities | 60,228 | 92,608 | 94,555 | 89,839 | 88,688 | 67,092 | 26,323 | 27,152 | 24,251 | 21,431 | 49,987 | 51,716 | 53,857 | 80,348 | 101,750 |
net assets | 95,668 | 110,140 | 103,723 | 129,912 | 113,467 | 323,268 | 331,853 | 304,647 | 273,773 | 231,789 | 236,936 | 221,524 | 202,023 | 189,869 | 188,519 |
total shareholders funds | 95,668 | 110,140 | 103,723 | 129,912 | 113,467 | 323,268 | 331,853 | 304,647 | 273,773 | 231,789 | 236,936 | 221,524 | 202,023 | 189,869 | 188,519 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | |||||||||||||||
Depreciation | 3,662 | 4,883 | 6,511 | 5,281 | 7,041 | 6,515 | 8,687 | 11,582 | 14,984 | 19,978 | 25,338 | 34,175 | |||
Amortisation | |||||||||||||||
Tax | |||||||||||||||
Stock | -5,155 | 16,754 | -2,083 | -11,966 | 854 | 71,924 | -102,278 | 6,393 | -1,755 | -1,320 | -2,485 | 2,669 | -3,956 | 102,732 | |
Debtors | -8,984 | 498 | 10,024 | -5,170 | -217,241 | -74,569 | 30,042 | 197,837 | 47,809 | -34,374 | -11,236 | 31,488 | -7,259 | 6,523 | 86,349 |
Creditors | -16,608 | -2,811 | 10,092 | -26,609 | 21,771 | 35,094 | -829 | 2,901 | 2,820 | -28,556 | -1,729 | -2,141 | -26,491 | -21,402 | 101,750 |
Accruals and Deferred Income | -15,720 | 1,747 | -6,132 | 25,056 | -175 | 5,675 | |||||||||
Deferred Taxes & Provisions | -52 | -883 | 756 | 2,704 | |||||||||||
Cash flow from operations | |||||||||||||||
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | |||||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | |||||||||||||||
Other Short Term Loans | |||||||||||||||
Long term loans | |||||||||||||||
Hire Purchase and Lease Commitments | |||||||||||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | |||||||||||||||
cash flow from financing | |||||||||||||||
cash and cash equivalents | |||||||||||||||
cash | -29,051 | -7,899 | -33,101 | 43,666 | 31,570 | 17,659 | -56,897 | -2,883 | 11,113 | 36,441 | 3,341 | 8,825 | 60 | ||
overdraft | |||||||||||||||
change in cash | -29,051 | -7,899 | -33,101 | 43,666 | 31,570 | 17,659 | -56,897 | -2,883 | 11,113 | 36,441 | 3,341 | 8,825 | 60 |
keats pharmacy limited Credit Report and Business Information
Keats Pharmacy Limited Competitor Analysis

Perform a competitor analysis for keats pharmacy limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in NW3 area or any other competitors across 12 key performance metrics.
keats pharmacy limited Ownership
KEATS PHARMACY LIMITED group structure
Keats Pharmacy Limited has no subsidiary companies.
keats pharmacy limited directors
Keats Pharmacy Limited currently has 1 director, Mr David Harvey serving since Sep 2023.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr David Harvey | United Kingdom | 70 years | Sep 2023 | - | Director |
P&L
December 2023turnover
398.5k
-13%
operating profit
-16.4k
0%
gross margin
36.6%
+0.97%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
95.7k
-0.13%
total assets
155.9k
-0.23%
cash
22.8k
-0.56%
net assets
Total assets minus all liabilities
keats pharmacy limited company details
company number
01673810
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
October 1982
age
43
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
j.m. weiner (chemists) limited (July 2003)
pullcare limited (September 1984)
accountant
AEQUITAS
auditor
-
address
30 rosslyn hill, hampstead, london, NW3 1NH
Bank
BARCLAYS BANK PLC
Legal Advisor
-
keats pharmacy limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to keats pharmacy limited. Currently there are 0 open charges and 2 have been satisfied in the past.
keats pharmacy limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for KEATS PHARMACY LIMITED. This can take several minutes, an email will notify you when this has completed.
keats pharmacy limited Companies House Filings - See Documents
date | description | view/download |
---|